{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:09:03Z","timestamp":1787587743006,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University in St Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajo.2024.11.017","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:41:27Z","timestamp":1733485287000},"page":"360-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Visual Field Progression in the Ocular Hypertension Treatment Study"],"prefix":"10.1016","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-796X","authenticated-orcid":false,"given":"Mae O.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9991-5072","authenticated-orcid":false,"given":"Dale K.","family":"Heuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve J.","family":"Higginbotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-338X","authenticated-orcid":false,"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-615X","authenticated-orcid":false,"given":"James D.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Huecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Phillip","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamila","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7071-1629","authenticated-orcid":false,"given":"Chris","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Keltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-630X","authenticated-orcid":false,"given":"Chris A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-4943","authenticated-orcid":false,"given":"Stuart K.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Liebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2024.11.017_bib0001","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archopht.117.5.573","article-title":"The ocular hypertension treatment study: design and baseline description of the participants","volume":"117","author":"Gordon","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.11.017_bib0002","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The ocular hypertension treatment study - a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.017_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaophthalmol.2021.0341","article-title":"Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 years of follow-up","volume":"139","author":"Kass","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2024.11.017_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-0420.1999.770201.x","article-title":"Inter-subject variability and normal limits of the SITA standard, SITA fast, and the Humphrey full threshold computerized perimetry strategies, SITA STATPAC","volume":"77","author":"Bengtsson","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.ajo.2024.11.017_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00061198-200002000-00005","article-title":"Comparison of the Humphrey Swedish interactive thresholding algorithm (SITA) and full threshold strategies","volume":"9","author":"Sharma","year":"2000","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2024.11.017_bib0006","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2018.11.006","article-title":"Assessment of the impact of an endpoint committee in the ocular hypertension treatment study","volume":"199","author":"Gordon","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.11.017_bib0007","series-title":"Generalized Additive Models. An Introduction with R","author":"Wood","year":"2017"},{"issue":"2","key":"10.1016\/j.ajo.2024.11.017_bib0008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","article-title":"A general and simple method for obtaining R2 from generalized linear mixed-effects models","volume":"4","author":"Nakagawa","year":"2013","journal-title":"Methods Ecol Evol"},{"key":"10.1016\/j.ajo.2024.11.017_bib0009","article-title":"R: A language and environment for statistical computing","volume":"1","author":"Team","year":"2014","journal-title":"MSOR connections"},{"issue":"7","key":"10.1016\/j.ajo.2024.11.017_bib0010","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2024.11.017_bib0011","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"British Journal of Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2024.11.017_bib0012","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/IJG.0000000000002260","article-title":"What is the optimal frequency of visual field testing to detect rapid progression among hypertensive eyes?","volume":"32","author":"Melchior","year":"2023","journal-title":"J Glaucoma"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.017_bib0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/IJG.0000000000002155","article-title":"Frequency of visual fields needed to detect glaucoma progression: a computer simulation using linear mixed effects model","volume":"32","author":"Sabouri","year":"2023","journal-title":"J Glaucoma"},{"issue":"1","key":"10.1016\/j.ajo.2024.11.017_bib0014","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1167\/iovs.10-7117","article-title":"The rate of visual field change in the ocular hypertension treatment study. randomized controlled trial, research support, N.I.H., extramural research support, Non-U.S. gov't","volume":"53","author":"Demirel","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2024.11.017_bib0015","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/BF00184085","article-title":"Modelling series of visual fields to detect progression in normal-tension glaucoma","volume":"233","author":"McNaught","year":"1995","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2024.11.017_bib0016","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/jamaophthalmol.2022.3273","article-title":"Rates of visual field change in patients with glaucoma and healthy individuals-findings from a median 25-year follow-up-reply","volume":"140","author":"Giammaria","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.11.017_bib0017","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1167\/iovs.10-6414","article-title":"A method to measure and predict rates of regional visual field decay in glaucoma","volume":"52","author":"Caprioli","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2024.11.017_bib0018","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1167\/iovs.13-12236","article-title":"Nonlinear, multilevel mixed-effects approach for modeling longitudinal standard automated perimetry data in glaucoma","volume":"54","author":"Pathak","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2024.11.017_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17469899.2016.1180246","article-title":"What rates of glaucoma progression are clinically significant?","volume":"11","author":"Saunders","year":"2016","journal-title":"Expert Rev Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.11.017_bib0020","first-page":"1419","article-title":"Analysis of progressive change in automated visual fields in glaucoma","volume":"37","author":"Smith","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2024.11.017_bib0021","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.ophtha.2009.04.031","article-title":"Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma","volume":"116","author":"Chauhan","year":"2009","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.017_bib0022","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","article-title":"Rates of visual field progression in clinical glaucoma care","volume":"91","author":"Heijl","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2024.11.017_bib0023","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1111\/aos.12788","article-title":"Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1","volume":"93","author":"Aptel","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.11.017_bib0024","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2009.06.042","article-title":"Early manifest glaucoma trial G. Natural history of open-angle glaucoma","volume":"116","author":"Heijl","year":"2009","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2024.11.017_bib0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archophthalmol.2011.72","article-title":"Risk factors for visual field progression in treated glaucoma","volume":"129","author":"De Moraes","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.11.017_bib0026","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1167\/iovs.15-19046","article-title":"Evaluation of glaucoma progression in large-scale clinical data: the Japanese archive of multicentral databases in glaucoma (JAMDIG)","volume":"57","author":"Fujino","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2024.11.017_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(86)90457-5","article-title":"The rate of progression of scotomas in glaucoma","volume":"101","author":"Mikelberg","year":"1986","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2024.11.017_bib0028","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/bjo.2009.164897","article-title":"On the accuracy of measuring rates of visual field change in glaucoma","volume":"94","author":"Jansonius","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.11.017_bib0029","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/eye.2015.161","article-title":"Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data","volume":"29","author":"Boodhna","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajo.2024.11.017_bib0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2020.05.019","article-title":"Rates of glaucomatous structural and functional change from a large clinical population: the duke glaucoma registry study","volume":"222","author":"Jammal","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.11.017_bib0031","series-title":"Clinical Decisions in Glaucoma","author":"Hodapp","year":"1993"},{"key":"10.1016\/j.ajo.2024.11.017_bib0032","doi-asserted-by":"crossref","unstructured":"Gordon MO, Beiser JA, Brandt JD, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-20.","DOI":"10.1001\/archopht.120.6.714"},{"key":"10.1016\/j.ajo.2024.11.017_bib0033","series-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1973"},{"key":"10.1016\/j.ajo.2024.11.017_bib0034","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajo.2019.06.019","article-title":"Risk factors for fast visual field progression in glaucoma","volume":"207","author":"Kim","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2024.11.017_bib0035","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2024.11.017_bib0036","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1167\/iovs.11-8639","article-title":"Incorporating risk factors to improve the assessment of rates of glaucomatous progression","volume":"53","author":"Medeiros","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2024.11.017_bib0037","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424005452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424005452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:55:53Z","timestamp":1778626553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424005452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"alternative-id":["S0002939424005452"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.11.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Field Progression in the Ocular Hypertension Treatment Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}